Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Jakub

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Annals of Surgical Oncology|August 9, 2015
Starting a Radioactive Seed Localization ProgramJames Jakub, Richard Gray
Expert Review of Anticancer Therapy|November 21, 2007
Molecular staging for patients with malignant melanomaSteve Shivers, James Jakub, Solange Pendas, et al.
Annals of Surgical Oncology|July 25, 2023
Overall Survival Following Neoadjuvant Chemotherapy Versus Adjuvant Chemotherapy in Clinically Node Negative T1 Triple Negative Breast CancerKai Huang, James Jakub, Emmanuel Gabriel, et al.
Annals of Surgical Oncology|November 5, 2004
Molecular staging of melanomaSteve Shivers, Marwan Alsarraj, Rosemary Guiliano, et al.
Seminars in Oncology|June 11, 2004
Worldwide experience with lymphatic mapping for invasive breast cancerSolange Pendas, Rosemary Giuliano, Gray Swor, et al.
World Journal of Surgical Oncology|May 5, 2023
Wide local excision, Mohs micrographic surgery, and reconstructive options for treatment of dermatofibrosarcoma protuberans of the breast: A retrospective case series from Mayo ClinicHiba Saifuddin, Maria Yan, James Jakub, et al.
Cancer Control : Journal of the Moffitt Cancer Center|July 31, 2004
The role of sentinel lymph node biopsy in patients with ductal carcinoma in situ or with locally advanced breast cancer receiving neoadjuvant chemotherapySolange Pendas, James Jakub, Rosemary Giuliano, et al.
The American Journal of Dermatopathology|March 10, 2020
Tumoral Melanosis in the Setting of Targeted Immunotherapy for Metastatic Melanoma-A Single Institutional Experience and Literature ReviewAndrea Jurgens, Swadha Guru, Ruifeng Guo, et al.
Breast Cancer (Tokyo, Japan)|November 20, 2004
Clinical considerations in breast cancer sentinel lymph node mapping: a Moffitt reviewCharles E Cox, Laura White, Nicholas Stowell, et al.
Seminars in Oncology|June 11, 2004
National trials involving lymphatic mapping for melanoma: the Multicenter Selective Lymphadenectomy Trial, the Sunbelt Melanoma Trial, and the Florida Melanoma TrialDouglas Reintgen, Solange Pendas, James Jakub, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Annals of Surgical Oncology|August 9, 2015
Starting a Radioactive Seed Localization ProgramJames Jakub, Richard Gray
Expert Review of Anticancer Therapy|November 21, 2007
Molecular staging for patients with malignant melanomaSteve Shivers, James Jakub, Solange Pendas, et al.
Annals of Surgical Oncology|July 25, 2023
Overall Survival Following Neoadjuvant Chemotherapy Versus Adjuvant Chemotherapy in Clinically Node Negative T1 Triple Negative Breast CancerKai Huang, James Jakub, Emmanuel Gabriel, et al.
Annals of Surgical Oncology|November 5, 2004
Molecular staging of melanomaSteve Shivers, Marwan Alsarraj, Rosemary Guiliano, et al.
Seminars in Oncology|June 11, 2004
Worldwide experience with lymphatic mapping for invasive breast cancerSolange Pendas, Rosemary Giuliano, Gray Swor, et al.
World Journal of Surgical Oncology|May 5, 2023
Wide local excision, Mohs micrographic surgery, and reconstructive options for treatment of dermatofibrosarcoma protuberans of the breast: A retrospective case series from Mayo ClinicHiba Saifuddin, Maria Yan, James Jakub, et al.
Cancer Control : Journal of the Moffitt Cancer Center|July 31, 2004
The role of sentinel lymph node biopsy in patients with ductal carcinoma in situ or with locally advanced breast cancer receiving neoadjuvant chemotherapySolange Pendas, James Jakub, Rosemary Giuliano, et al.
The American Journal of Dermatopathology|March 10, 2020
Tumoral Melanosis in the Setting of Targeted Immunotherapy for Metastatic Melanoma-A Single Institutional Experience and Literature ReviewAndrea Jurgens, Swadha Guru, Ruifeng Guo, et al.
Breast Cancer (Tokyo, Japan)|November 20, 2004
Clinical considerations in breast cancer sentinel lymph node mapping: a Moffitt reviewCharles E Cox, Laura White, Nicholas Stowell, et al.
Seminars in Oncology|June 11, 2004
National trials involving lymphatic mapping for melanoma: the Multicenter Selective Lymphadenectomy Trial, the Sunbelt Melanoma Trial, and the Florida Melanoma TrialDouglas Reintgen, Solange Pendas, James Jakub, et al.
Pageof 2